101 related articles for article (PubMed ID: 16299292)
1. Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity.
Polley R; Sanos SL; Prickett S; Haque A; Kaye PM
Infect Immun; 2005 Dec; 73(12):7996-8001. PubMed ID: 16299292
[TBL] [Abstract][Full Text] [Related]
2. The fate of heterologous CD4+ T cells during Leishmania donovani infection.
Polley R; Zubairi S; Kaye PM
Eur J Immunol; 2005 Feb; 35(2):498-504. PubMed ID: 15682458
[TBL] [Abstract][Full Text] [Related]
3. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
4. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
5. B-cell activating factor deficiency suppresses splenomegaly during Leishmania donovani infection.
Omachi S; Fujii W; Azuma N; Morimoto A; Sanjoba C; Matsumoto Y; Goto Y
Biochem Biophys Res Commun; 2017 Aug; 489(4):528-533. PubMed ID: 28583852
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis.
Guha R; Gupta D; Rastogi R; Vikram R; Krishnamurthy G; Bimal S; Roy S; Mukhopadhyay A
Sci Transl Med; 2013 Sep; 5(202):202ra121. PubMed ID: 24027025
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.
Haque A; Stanley AC; Amante FH; Rivera Fde L; Zhou Y; Kuns RD; Yardley V; Sakaguchi S; Hill GR; Engwerda CR
J Immunol; 2010 Mar; 184(5):2583-92. PubMed ID: 20139272
[TBL] [Abstract][Full Text] [Related]
8. IRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania Infection.
Hammami A; Charpentier T; Smans M; Stäger S
PLoS Pathog; 2015 Jun; 11(6):e1004938. PubMed ID: 26046638
[TBL] [Abstract][Full Text] [Related]
9. CD40 signaling in CD8+CD40+ T cells turns on contra-T regulatory cell functions.
Martin S; Pahari S; Sudan R; Saha B
J Immunol; 2010 May; 184(10):5510-8. PubMed ID: 20400702
[TBL] [Abstract][Full Text] [Related]
10. IRF-5 Expression in Myeloid Cells Is Required for Splenomegaly in
Mai LT; Smans M; Silva-Barrios S; Fabié A; Stäger S
Front Immunol; 2019; 10():3071. PubMed ID: 32038622
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium berghei sporozoite challenge of vaccinated BALB/c mice leads to the induction of humoral immunity and improved function of CD8(+) memory T cells.
Tartz S; Deschermeier C; Retzlaff S; Heussler V; Sebo P; Fleischer B; Jacobs T
Eur J Immunol; 2013 Mar; 43(3):693-704. PubMed ID: 23229763
[TBL] [Abstract][Full Text] [Related]
12. Leishmania-infected MHC class IIhigh dendritic cells polarize CD4+ T cells toward a nonprotective T-bet+ IFN-γ+ IL-10+ phenotype.
Resende M; Moreira D; Augusto J; Cunha J; Neves B; Cruz MT; Estaquier J; Cordeiro-da-Silva A; Silvestre R
J Immunol; 2013 Jul; 191(1):262-73. PubMed ID: 23729437
[TBL] [Abstract][Full Text] [Related]
13. PDL-1 Blockade Prevents T Cell Exhaustion, Inhibits Autophagy, and Promotes Clearance of Leishmania donovani.
Habib S; El Andaloussi A; Elmasry K; Handoussa A; Azab M; Elsawey A; Al-Hendy A; Ismail N
Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29610255
[No Abstract] [Full Text] [Related]
14. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
Melby PC; Yang J; Zhao W; Perez LE; Cheng J
Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
[TBL] [Abstract][Full Text] [Related]
15. Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes.
Narni-Mancinelli E; Campisi L; Bassand D; Cazareth J; Gounon P; Glaichenhaus N; Lauvau G
J Exp Med; 2007 Sep; 204(9):2075-87. PubMed ID: 17698589
[TBL] [Abstract][Full Text] [Related]
16. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
[TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis.
Das P; Amit A; Singh SK; Chaudhary R; Dikhit MR; Yadav A; Pandey K; Das VN; Sundram S; Das P; Bimal S
Parasitol Int; 2015 Feb; 64(1):18-25. PubMed ID: 25224164
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis.
Kumari S; Jamal F; Shivam P; Thakur A; Kumar M; Bimal S; Das VN; Pandey K; Narayan S; Gupta AK; Das P; Singh SK
Cytokine; 2015 May; 73(1):53-60. PubMed ID: 25697139
[TBL] [Abstract][Full Text] [Related]
19. Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.
Murray HW; Stern JJ; Welte K; Rubin BY; Carriero SM; Nathan CF
J Immunol; 1987 Apr; 138(7):2290-7. PubMed ID: 3104456
[TBL] [Abstract][Full Text] [Related]
20. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
Rachamim N; Jaffe CL
J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
